Biotech

All Articles

Novo inks $600M NanoVation bargain to research genetic medicines ex-liver

.Novo Nordisk is actually continuing its own push into genetic medicines, consenting to pay NanoVati...

Innovent hyperlinks cytokine to intestines cancer cells feedbacks

.Innovent Biologics has made the situation that its own checkpoint inhibitor-cytokine fusion protein...

Merck, Daiichi ADC strikes goal in phase 3 bronchi cancer cells study

.A stage 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina grows AI focus along with collab to choose cancer aim ats

.5 months after Rakovina Therapeutics rotated toward artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism drug favorites in phase 3, intimidates BioMarin

.Ascendis Pharma has actually become a possible threat to BioMarin's Voxzogo, disclosing period 3 de...

Despite ph. 3 skip, Alkeus observes path ahead for eye disease resource

.Though Alkeus Pharmaceuticals' oral eye ailment resource neglected to significantly reduce geograph...

Kairos goes public with $6M IPO to finance tests of cancer cells medication

.Along with a triad of biotechs striking the Nasdaq on Friday, it was simple to overlook a smaller-s...

Vaccine and Keytruda combination successful in squamous cell carcinoma

.Immune checkpoint inhibitors are actually the superheroes of cancer cells therapy. Medications like...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings and a...

Regeneron's Opdualag rival presents 57% reaction cost

.Regeneron is actually back with long-term consequence for its LAG-3 inhibitor as well as PD-1 preve...